ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer

Huang, Hongliang; Dai, Yuexiang; Duan, Yingying; Yuan, Zhongwen; Li, Yanxuan; Zhang, Maomao; Zhu, Wenting; Yu, Hang; Zhong, Wenfei*; Feng, Senling*广东药学院; 广州医学院; 5
Frontiers in Oncology2022-10-17DOI: 10.3389/fonc.2022.1033044
3被引10阅读
引用收藏
分享

摘要

BackgroundColon cancer is common worldwide, with high morbidity and poor prognosis. Ferroptosis is a novel form of cell death driven by the accumulation of iron-dependent lipid peroxides, which differs from other programmed cell death mechanisms. Programmed cell death is a cancer hallmark, and ferroptosis is known to participate in various cancers, including colon cancer. Novel ferroptosis markers and targeted colon cancer therapies are urgently needed. To this end, we performed a preliminary exploration of ferroptosis-related genes in colon cancer to enable new treatment strategies. MethodsFerroptosis-related genes in colon cancer were obtained by data mining and screening for differentially expressed genes (DEGs) using bioinformatics analysis tools. We normalized the data across four independent datasets and a ferroptosis-specific database. Identified genes were validated by immunohistochemical analysis of pathological and healthy clinical samples. ResultsWe identified DEGs in colon cancer that are involved in ferroptosis. Among these, five core genes were found: ELAVL1, GPX2, EPAS1, SLC7A5, and HMGB1. Bioinformatics analyses revealed that the expression of all five genes, except for EPAS1, was higher in tumor tissues than in healthy tissues. ConclusionsThe preliminary exploration of the five core genes revealed that they are differentially expressed in colon cancer, playing an essential role in ferroptosis. This study provides a foundation for subsequent research on ferroptosis in colon cancer.

学科与关键词

关键词
bioinformaticscolon cancerferroptosisdifferentially expressed genesdata mininglipid peroxidation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-10-17
卷期
第 12 卷
页码
1033044
DOI
10.3389/fonc.2022.1033044
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82104446]; Guangdong Basic and Applied Basic Research Foundation [2019A1515111109]; Guangdong Province Characteristic Innovation Project of universities [2022KTSCX100]; Yiwen Talent Project; Academician He Lin New Medical Research Foundation [2021HLKY02]

作者

  • H

    Huang, Hongliang (第一作者)

    guangzhou med univ

  • D

    Dai, Yuexiang

    guangdong pharmaceut univ

查看全部 10 位作者收起作者
  • D

    Duan, Yingying

    guangzhou med univ

  • Y

    Yuan, Zhongwen

    guangzhou med univ

  • L

    Li, Yanxuan

    5 · guangzhou med univ

  • Z

    Zhang, Maomao

    5 · guangzhou med univ

  • Z

    Zhu, Wenting

    guangzhou med univ

  • Y

    Yu, Hang

    guangzhou med univ

  • Z

    Zhong, Wenfei (通讯)

    guangzhou med univ

  • F

    Feng, Senling (通讯)

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417